Hubei Guangji Pharmaceutical Co Ltd Free Cash Flow Generation Index
Hubei Guangji Pharmaceutical Co Ltd free cash flow generation index. Hubei Guangji Pharmaceutical Co Ltd (000952) has a Free Cash Flow Generation Index of 0.61x as of September 2025. Free cash flow of CN¥13.71 Million represents 1% of operating cash flow (CN¥22.38 Million). Check how resilient are Hubei Guangji Pharmaceutical Co Ltd's assets to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Hubei Guangji Pharmaceutical Co Ltd (1999–2025)
Free cash flow generation index of Hubei Guangji Pharmaceutical Co Ltd from 1999 to 2025. Historical FCF Generation Index trend for Hubei Guangji Pharmaceutical Co Ltd across 20 annual periods. Explore Hubei Guangji Pharmaceutical Co Ltd (000952) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Hubei Guangji Pharmaceutical Co Ltd Free Cash Flow Generation Index by Year (1999–2025)
Hubei Guangji Pharmaceutical Co Ltd free cash flow generation index by year from 1999 to 2025. Year-by-year Free Cash Flow Generation Index for Hubei Guangji Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Hubei Guangji Pharmaceutical Co Ltd (000952) cash flow conversion.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.41x | CN¥24.79 Million | CN¥60.43 Million | CN¥35.64 Million | ▲ +100.2% |
| 2024 | -235.41x | CN¥-154.28 Million | CN¥655.36K | CN¥154.93 Million | ▼ -6590.0% |
| 2022 | -3.52x | CN¥-158.63 Million | CN¥45.08 Million | CN¥203.71 Million | ▼ -1190.4% |
| 2021 | -0.27x | CN¥-20.70 Million | CN¥75.91 Million | CN¥96.61 Million | ▼ -251.5% |
| 2020 | 0.18x | CN¥21.49 Million | CN¥119.38 Million | CN¥97.89 Million | ▲ +6.2% |
| 2019 | 0.17x | CN¥24.44 Million | CN¥144.20 Million | CN¥119.76 Million | ▼ -74.7% |
| 2018 | 0.67x | CN¥154.91 Million | CN¥231.44 Million | CN¥76.53 Million | ▲ +22.2% |
| 2017 | 0.55x | CN¥97.92 Million | CN¥178.83 Million | CN¥80.91 Million | ▲ +69.0% |
| 2016 | 0.32x | CN¥54.13 Million | CN¥167.07 Million | CN¥112.94 Million | ▼ -31.7% |
| 2013 | 0.47x | CN¥45.12 Million | CN¥95.16 Million | CN¥50.04 Million | ▲ +642.6% |
| 2012 | -0.09x | CN¥-9.44 Million | CN¥108.02 Million | CN¥117.46 Million | ▲ +94.0% |
| 2011 | -1.45x | CN¥-119.08 Million | CN¥81.88 Million | CN¥200.96 Million | ▼ -192.4% |
| 2010 | -0.50x | CN¥-38.39 Million | CN¥77.18 Million | CN¥115.57 Million | ▼ -11809.9% |
| 2008 | 0.00x | CN¥937.45K | CN¥220.70 Million | CN¥219.76 Million | ▼ -99.5% |
| 2007 | 0.85x | CN¥283.03 Million | CN¥331.98 Million | CN¥48.94 Million | ▲ +0.1% |
| 2006 | 0.85x | CN¥107.23 Million | CN¥125.95 Million | CN¥18.73 Million | ▲ +62.9% |
| 2005 | 0.52x | CN¥28.30 Million | CN¥54.14 Million | CN¥25.84 Million | ▲ +55.1% |
| 2002 | 0.34x | CN¥25.68 Million | CN¥76.20 Million | CN¥50.52 Million | ▼ -30.2% |
| 2000 | 0.48x | CN¥23.46 Million | CN¥48.57 Million | CN¥25.11 Million | ▲ +149.4% |
| 1999 | -0.98x | CN¥-67.01 Million | CN¥68.57 Million | CN¥135.58 Million | — |